Researchers Use AI to Predict Lifespan and Health Based on Blood Data

Published On 2024-12-31 03:00 GMT   |   Update On 2024-12-31 03:00 GMT

A recent study showed that a metabolomic clock developed using a specific machine learning algorithm, called Cubist rule-based regression, was most strongly associated with most health and ageing markers. They also found that algorithms which can model non-linear relationships between metabolites and age generally performed best at capturing biological signal informative of health and lifespan. The study was published in Science Advances

Researchers conducted a comprehensive study to evaluate artificial intelligence based ageing clocks, which predict health and lifespan using data from blood.

The researchers trained and tested 17 machine learning algorithms using data on markers in the blood from over 225,000 UK Biobank participants, aged 40 to 69 years when they were recruited.

A person's metabolomic age, their "MileAge," is a measure of how old their body seems to be on the inside based on markers in the blood called metabolites. The difference between a person's metabolite-predicted age and their chronological age, termed MileAge delta, indicates whether their biological ageing is accelerated or decelerated.

Individuals with accelerated ageing were, on average, frailer, more likely to have a chronic illness, rated their health worse, and had a higher mortality risk. They also had shorter telomeres, which are a marker of cellular ageing and linked with age-related diseases such as atherosclerosis. However, decelerated biological ageing was only weakly linked with good health.

Ageing clocks could help spot early signs of declining health, enabling preventative strategies and interventions before disease onset. They may also allow people to proactively track their health, make better lifestyle choices, and take steps to stay healthy for longer.

Reference: https://www.kcl.ac.uk/news/researchers-ai-ageing-clocks-predict-health-lifespan

A recent study showed that a metabolomic clock developed using a specific machine learning algorithm, called Cubist rule-based regression, was most strongly associated with most health and ageing markers. They also found that algorithms which can model non-linear relationships between metabolites and age generally performed best at capturing biological signal informative of health and lifespan. The study was published in Science Advances

Researchers conducted a comprehensive study to evaluate artificial intelligence based ageing clocks, which predict health and lifespan using data from blood.

The researchers trained and tested 17 machine learning algorithms using data on markers in the blood from over 225,000 UK Biobank participants, aged 40 to 69 years when they were recruited.

A person's metabolomic age, their "MileAge," is a measure of how old their body seems to be on the inside based on markers in the blood called metabolites. The difference between a person's metabolite-predicted age and their chronological age, termed MileAge delta, indicates whether their biological ageing is accelerated or decelerated.

Individuals with accelerated ageing were, on average, frailer, more likely to have a chronic illness, rated their health worse, and had a higher mortality risk. They also had shorter telomeres, which are a marker of cellular ageing and linked with age-related diseases such as atherosclerosis. However, decelerated biological ageing was only weakly linked with good health.

Ageing clocks could help spot early signs of declining health, enabling preventative strategies and interventions before disease onset. They may also allow people to proactively track their health, make better lifestyle choices, and take steps to stay healthy for longer.

Reference: https://www.kcl.ac.uk/news/researchers-ai-ageing-clocks-predict-health-lifespan

Full View
Tags:    
Article Source : Science Advances

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News